These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30229578)

  • 21. Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study.
    Caturano A; Galiero R; Loffredo G; Vetrano E; Medicamento G; Acierno C; Rinaldi L; Marrone A; Salvatore T; Monda M; Sardu C; Marfella R; Sasso FC
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease.
    Mino M; Kakazu E; Sano A; Katsuyama H; Hakoshima M; Yanai H; Aoki Y; Imamura M; Yamazoe T; Mori T; Yoshio S; Inoue J; Masamune A; Kanto T
    Hepatol Res; 2023 Jul; 53(7):618-628. PubMed ID: 36905232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.
    Wong CA; Araneta MR; Barrett-Connor E; Alcaraz J; Castañeda D; Macera C
    Diabetes Res Clin Pract; 2008 Jan; 79(1):133-40. PubMed ID: 17764776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dapagliflozin against NAFLD and dyslipidemia in type 2 diabetic albino rats: possible underlying mechanisms.
    Said Ahmed WM; Soliman A; Ahmed Amer AE; El Shahat RM; Amin MM; Taha RS; Awad MMY; Abdel Hamid AM; El-Sayed MS; Eid EA; Dmerdash M; Ali HE; Fayed EMM; Naeem SAM; Elsharawy AF; Elzahaby OMAM; Ayoub MK; Mohammed DA
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8101-8109. PubMed ID: 37750638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Pharmacotherapeutic Profile of Patients with Type 2 Diabetes Mellitus Admitted to a Hospital Emergency Department.
    Lopes AC; Lourenço O; Roque F; Morgado M
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications.
    Bellido V; Martínez J; Calvo F; Villarroel A; Lecumberri E; Moreno J; Morillas C; Rodrigo S; Izarra A; Lecube A
    Diabetes Ther; 2022 May; 13(5):873-888. PubMed ID: 35338446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan.
    Yano K; Seko Y; Takahashi A; Okishio S; Kataoka S; Takemura M; Okuda K; Mizuno N; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
    Diagnostics (Basel); 2020 Feb; 10(2):. PubMed ID: 32041289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings.
    Sharma K; Chandorkar AB; Kovil R; Venkataraman S; Subrahmanyam K; Mandal P; Wasir J; Abhyankar M; Prasad A; Sarda PS
    Cureus; 2021 Nov; 13(11):e19194. PubMed ID: 34877189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity.
    Lee JG; Kang DG; Yu JR; Kim Y; Kim J; Koh G; Lee D
    Diabetes Metab J; 2011 Apr; 35(2):149-58. PubMed ID: 21738897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperglycemia not associated with NAFLD improvement in children with type 2 diabetes mellitus.
    Beauchamp G; Barr MM; Vergara A; Ashraf A; Bril F
    Int J Pediatr Adolesc Med; 2022 Jun; 9(2):83-88. PubMed ID: 35663787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey.
    Das C; Tripathy D; Swain S; Sudhakaran N; Uthansingh K; Mallick P; Pati GK
    Cureus; 2021 May; 13(5):e14974. PubMed ID: 34123670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health.
    Moolla A; Motohashi K; Marjot T; Shard A; Ainsworth M; Gray A; Holman R; Pavlides M; Ryan JD; Tomlinson JW; Cobbold JF
    Frontline Gastroenterol; 2019 Oct; 10(4):337-346. PubMed ID: 31682643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of adding Dapagliflozin in patients with nephrotic syndrome.
    ElSharkawy M; Emara A; Ahmed MM; Ghonamy E; Teama NM
    Int Urol Nephrol; 2024 Jun; ():. PubMed ID: 38862701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Comparation of Renal Anti-Senescence Effects and Blood Metabolites between Dapagliflozin and Metformin in Non-Diabetes Environment.
    Zeng L; Chen L; Gao F; Li J; Song Y; Wei L; Qu N; Li Y; Jiang H
    Adv Biol (Weinh); 2023 Oct; 7(10):e2300199. PubMed ID: 37688360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus.
    Kong SH; Koo BK; Moon MK
    Diabetes Metab J; 2019 Oct; 43(5):711-717. PubMed ID: 30968615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.
    Shah C; Hong YR; Bishnoi R; Ali A; Skelton WP; Dang LH; Huo J; Dang NH
    Front Oncol; 2020; 10():405. PubMed ID: 32296640
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Dapagliflozin Combined with Cognitive Behavior Training on Quality of Life and Cognitive Function in Elderly Patients with Type 2 Diabetes Mellitus Complicated with Mild Cognitive Impairment.
    Zhao Y; Zhang R; Wang S
    Iran J Public Health; 2022 Jun; 51(6):1251-1258. PubMed ID: 36447989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapagliflozin-Induced Acute-on-Chronic Liver Injury.
    Levine JA; Ann Lo A; Wallia A; Rogers M; VanWagner LB
    ACG Case Rep J; 2016 Aug; 3(4):e169. PubMed ID: 28008402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease, diabetes medications and blood pressure.
    Ilias I; Thomopoulos C
    World J Diabetes; 2021 Oct; 12(10):1809-1811. PubMed ID: 34754380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.